A randomized, double-blind placebo-controlled single-to multiple-dose escalation study to investigate the safety, tolerability and pharmacokinetics of RSV604 intravenous formulation in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2011
At a glance
- Drugs RSV 604 (Primary)
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions
- 01 Nov 2011 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
- 21 Jun 2007 Status change from in progress to completed
- 01 Feb 2007 New trial record.